Get 20% Free Customization In This Report

Buy this report from - $3456

Global Chlorhexidine Gluconate Solution Market - Opportunity Analysis and Industry Forecast, 2017-2023

Renewable, Speciality and fine chemicals	MA_183822	Pages: NA	May 2018 \| 367 Views
Author's : NA	Tables: NA	Charts: NA	Formats*:

Chlorhexidine gluconate solution is a topical antibiotic used for multiple external applications. It is an aqueous solution of chlorhexidine gluconate. It contains NLT 19.0% and NMT 21.0% of chlorhexidine gluconate.

Rise in number of surgical procedures with rise in prevalence & incidence of various chronic diseases, and increase in aging population drive the demand for chlorhexidine gluconate solution. Unexpected fluctuations in raw materials prices restrict the market growth. In addition, stringent government regulations associated with the usage of chemicals hamper the market growth during the forecast period.

The report segments the chlorhexidine gluconate solution market on the basis of application and geography. Based on application, it is divided into preoperative skin preparation, surgical hand scrub, healthcare personnel hand hygiene and skin wound & general skin cleanser. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of major market players such as H&R Healthcare Ltd., Cadila Pharmaceuticals Ltd., Basic Pharma Life Science Pvt. Ltd., PSK Pharma Pvt. Ltd., Proton Pharma Private Limited, Abhilasha Pharma Pvt. Ltd., Neelkanth Healthcare Pvt. Ltd., Afton Pharma, Glide Chem Private Limited, and Sceptre Medical India Private Limited is also provided in the report.

Key Benefits

This report provides a quantitative analysis of the current trends and estimations from 2017 to 2023 of the global chlorhexidine gluconate solution market to identify the prevailing market opportunities.
Major countries in each region are mapped according to individual market revenue.
Comprehensive analysis of factors that drive and restrict the market growth is provided.
An in-depth analysis of current research & clinical developments within the market is provided with key dynamic factors.
Key players and their key developments in the recent years are listed.

Chlorhexidine Gluconate Solution Market Key Segments:

By Application

Preoperative Skin Preparation
Surgical Hand Scrub
Healthcare Personnel Hand Hygiene
Skin Wound & General Skin Cleanser

By Geography

North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- South Africa
- Argentina
- Turkey
- Rest of LAMEA

Other Market Players

Dwarkesh Pharmaceuticals Pvt. Ltd.
Microlab Limited
Intas Pharmaceuticals Ltd
Lupin Ltd.
Cipla Ltd.
Wockhardt Ltd.
Sun Pharma Ltd.
Hicks Themometer (India) Ltd
Dev Life Corporation
Cian Healthcare Private Limited
Cardinal Health
R. N. Laboratories Pvt. Ltd.

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS

3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities

Chapter: 4 GLOBAL CHLORHEXIDINE GLUCONATE SOLUTION MARKET, BY APPLICATION

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. PREOPERATIVE SKIN PREPARATION

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. SURGICAL HAND SCRUB

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. HEALTHCARE PERSONNEL HAND HYGIENE

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

4.5. SKIN WOUND & GENERAL SKIN CLEANSER

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast

Chapter: 5 GLOBAL CHLORHEXIDINE GLUCONATE SOLUTION MARKET, BY GEOGRAPHY

5.1. OVERVIEW
5.2. NORTH AMERICA

5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast

5.2.3.1. By Application

5.2.4. U.S.

5.2.4.1. Market size and forecast, by Application

5.2.5. Canada

5.2.5.1. Market size and forecast, by Application

5.2.6. Mexico

5.2.6.1. Market size and forecast, by Application

5.3. EUROPE

5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast

5.3.3.1. By Application

5.3.4. Germany

5.3.4.1. Market size and forecast, by Application

5.3.5. France

5.3.5.1. Market size and forecast, by Application

5.3.6. UK

5.3.6.1. Market size and forecast, by Application

5.3.7. Italy

5.3.7.1. Market size and forecast, by Application

5.3.8. Rest of Europe

5.3.8.1. Market size and forecast, by Application

5.4. ASIA-PACIFIC

5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast

5.4.3.1. By Application

5.4.4. China

5.4.4.1. Market size and forecast, by Application

5.4.5. Japan

5.4.5.1. Market size and forecast, by Application

5.4.6. India

5.4.6.1. Market size and forecast, by Application

5.4.7. Australia

5.4.7.1. Market size and forecast, by Application

5.4.8. Korea

5.4.8.1. Market size and forecast, by Application

5.4.9. Rest of Asia-Pacific

5.4.9.1. Market size and forecast, by Application

5.5. LAMEA

5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast

5.5.3.1. By Application

5.5.4. Brazil

5.5.4.1. Market size and forecast, by Application

5.5.5. Saudi Arabia

5.5.5.1. Market size and forecast, by Application

5.5.6. South Africa

5.5.6.1. Market size and forecast, by Application

5.5.7. Rest of LAMEA

5.5.7.1. Market size and forecast, by Application

Chapter: 6 COMPANY PROFILES

6.1. H&R HEALTHCARE LTD.

6.1.1. Operating business segments
6.1.2. Business performance
6.1.3. Key strategic moves and developments

6.2. CADILA PHARMACEUTICALS LTD.

6.2.1. Operating business segments
6.2.2. Business performance
6.2.3. Key strategic moves and developments

6.3. BASIC PHARMA LIFE SCIENCE PVT. LTD.

6.3.1. Operating business segments
6.3.2. Business performance
6.3.3. Key strategic moves and developments

6.4. PSK PHARMA PVT. LTD.

6.4.1. Operating business segments
6.4.2. Business performance
6.4.3. Key strategic moves and developments

6.5. PROTON PHARMA PRIVATE LIMITED

6.5.1. Operating business segments
6.5.2. Business performance
6.5.3. Key strategic moves and developments

6.6. ABHILASHA PHARMA PVT. LTD.

6.6.1. Operating business segments
6.6.2. Business performance
6.6.3. Key strategic moves and developments

6.7. NEELKANTH HEALTHCARE PVT. LTD.

6.7.1. Operating business segments
6.7.2. Business performance
6.7.3. Key strategic moves and developments

6.8. AFTON PHARMA

6.8.1. Operating business segments
6.8.2. Business performance
6.8.3. Key strategic moves and developments

6.9. GLIDE CHEM PRIVATE LIMITED

6.9.1. Operating business segments
6.9.2. Business performance
6.9.3. Key strategic moves and developments

6.10. SCEPTRE MEDICAL INDIA PRIVATE LIMITED

6.10.1. Operating business segments
6.10.2. Business performance
6.10.3. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.